LivaNova

World Rank (Jan-05-2024)

4,732

Market Cap (Jan-05-2024)

2.683 Billion USD

World Rank (Jul-30-2023)

4,247

Market Cap (Jul-30-2023)

3.108 Billion USD

World Rank (Jan-07-2022)

3,621

Market Cap (Jan-07-2022)

4.395 Billion USD

World Rank (Jan-01-2021)

4,094

Market Cap (Jan-01-2021)

3.218 Billion USD

Company Rank in Country in 2023

Company rank in UK in July-2023 is 149

Headquarters Country

UK

Nasdaq / NYSE Code

LIVN

Market Cap (Mar-08-2026)

3.49

Employee Count

4,000

Employee Count as of Date

As on 2020

World Region

Europe

World Subregion

Northern Europe

Annual Revenue in USD

1,035 Million USD

Annual Net Income in USD

-135 Million USD

Annual Results for Period Ending

Dec-2021 ending year

Total Assets in USD

2,200 Million USD

Total Liabilities in USD

906 Million USD

Total Equity in USD

1,294 Million USD

Balance Sheet for Period Ending

Dec-2021 ending year

Business Sector

Healthcare

Biotechnology

Medical Equipment / Instruments

Company Website

Yahoo

Company Profile

LivaNova is a Medical Technology company. The company products and therapies are neuromodulation, resources and cardiovascular. It offers a diverse product portfolio with a differentiated pipeline and reach is broad with a presence in more than 100 countries and approximately 4,000 employees. The headquarters is in UK.

Annual Results Summary

LIVANOVA - Yearly Revenue and Net Income - in Million USD:

Year - Ending	Revenue	Operating Income	Net Income
Dec-2023	1,153	21	17
Dec-2022	1,021	52	-86 (Loss)
Dec-2021	1,035	-0.8 (Loss)	-135 (Loss)
Dec-2020	934	-43 (Loss)	-345 (Loss)
Dec-2019	1,084	48	-155 (Loss)